Infu-Tech Appoints Edward J. Letko President and CEO; Healthcare and E-Health Veteran to Extend Company's Strategic Reach

Apr 26, 2001, 01:00 ET from Infu-Tech, Inc.

    CARLSTADT, N.J., April 26 /PRNewswire/ -- Infu-Tech, Inc. (Nasdaq: INFU),
 a leading provider of specialty pharmaceuticals, announced that it has
 appointed healthcare veteran, Edward J. Letko, as president and chief
 executive officer effective immediately. Commenting or the appointment,
 Infu-Tech Chairman, Jack Rosen said, "The Company is currently building
 Smartmeds.com's wireless healthcare application and extending the reach of its
 specialty pharmaceutical distribution businesses. It is the correct time to
 bring on board an executive leader with sales and marketing skills in our
 field to take the company to the next level. I am pleased to welcome Edward to
 the company. His mandate is to strengthen the management of Infu-Tech and its
 subsidiary, Smartmeds.com, to facilitate growth and the continuing evolution
 of our business."
     Mr. Rosen, who retains the title of Chairman of the Board, plans to focus
 his attention going forward on other interests, as will Dan Rosen. Dan who has
 been serving as president and COO of Infu-Tech and CEO of Smartmeds.com will
 serve in the transitional role as a strategist for Smartmeds.com. In
 commenting on Edward Letko's appointment, Dan said, "I joined Infu-Tech to
 build Smartmeds.com's e-health platform. Now that it has been launched,
 different leadership is needed to strengthen Infu-Tech's core business. Edward
 Letko brings his enthusiasm and experience in the healthcare industry."
     Edward J. Letko has 14 years experience in establishing, managing and
 growing medical distribution, pharmacy and infusion businesses. Mr. Letko, 33,
 is a graduate of Columbia University with a BA in Political Science.
     Commenting on his new position, Letko said, "I'm looking forward to
 leading Infu-Tech in strengthening its core business while continuing to grow
 the e-health model that is already underway. This build-out is dependent on
 specialty pharmaceutical sales, a core competency at Infu-Tech, and one that
 we intend to expand through the Smartmeds.com applications."
     Smartmeds.com's recent launch of Smartmedsmobile.com connects individuals
 via their Internet enabled wireless phone to a unique service that will
 empower them to better manage their health via a customized program developed
 to facilitate their daily drug and disease management requirements. Subscriber
 information about this new interactive wireless health service is available at
 http://www.smartmedsmobile.com.
 
     About Infu-Tech/SmartMeds.com
     Infu-Tech is a leading provider of specialty pharmaceuticals and medical
 services. With more than 15 years clinical experience and managed care
 relationships with the enrollees of HMOs, large employer groups, Medicare and
 Medicaid, Infu-Tech has earned a reputation for patient satisfaction and
 clinically proven success in delivering high levels of service to special
 needs patients. Infu-Tech has extended its company's interaction with patients
 via its http://www.smartmeds.com website and Smartmedsmobile.com wireless
 initiative. The Smartmeds.com website includes an online pharmacy, interaction
 with medical professionals, and facilitates the ordering of specialty
 medications and other medical products. Infu-Tech is accredited by the Joint
 Commission on Accreditation of Health Care Organizations (JCAHO), and the
 company's products and services are marketed nationally, Infu-Tech is a
 publicly traded company, NASDAQ SMALLCAP: INFU.
 
     Certain statements contained in this release are forward-looking. Although
 Infu-Tech, Inc. believes that its expectations are based on reasonable
 assumptions within the bounds of its knowledge of its business and operations,
 there can be no assurance that actual results will not differ materially from
 its expectations. Factors that could cause actual results to differ from
 expectations include the difficulty in controlling healthcare costs.
 Integrating new operations from acquired companies and the possible negative
 effects of prospective healthcare reform. For other important factors that may
 cause actual results to differ materially from expectations and underlying
 assumptions, see reports by Infu-Tech, Inc. filed with the Securities and
 Exchange Commission.
 
                     MAKE YOUR OPINION COUNT -- Click Here
                http://tbutton.prnewswire.com/prn/11690X62112265
 
 

SOURCE Infu-Tech, Inc.
    CARLSTADT, N.J., April 26 /PRNewswire/ -- Infu-Tech, Inc. (Nasdaq: INFU),
 a leading provider of specialty pharmaceuticals, announced that it has
 appointed healthcare veteran, Edward J. Letko, as president and chief
 executive officer effective immediately. Commenting or the appointment,
 Infu-Tech Chairman, Jack Rosen said, "The Company is currently building
 Smartmeds.com's wireless healthcare application and extending the reach of its
 specialty pharmaceutical distribution businesses. It is the correct time to
 bring on board an executive leader with sales and marketing skills in our
 field to take the company to the next level. I am pleased to welcome Edward to
 the company. His mandate is to strengthen the management of Infu-Tech and its
 subsidiary, Smartmeds.com, to facilitate growth and the continuing evolution
 of our business."
     Mr. Rosen, who retains the title of Chairman of the Board, plans to focus
 his attention going forward on other interests, as will Dan Rosen. Dan who has
 been serving as president and COO of Infu-Tech and CEO of Smartmeds.com will
 serve in the transitional role as a strategist for Smartmeds.com. In
 commenting on Edward Letko's appointment, Dan said, "I joined Infu-Tech to
 build Smartmeds.com's e-health platform. Now that it has been launched,
 different leadership is needed to strengthen Infu-Tech's core business. Edward
 Letko brings his enthusiasm and experience in the healthcare industry."
     Edward J. Letko has 14 years experience in establishing, managing and
 growing medical distribution, pharmacy and infusion businesses. Mr. Letko, 33,
 is a graduate of Columbia University with a BA in Political Science.
     Commenting on his new position, Letko said, "I'm looking forward to
 leading Infu-Tech in strengthening its core business while continuing to grow
 the e-health model that is already underway. This build-out is dependent on
 specialty pharmaceutical sales, a core competency at Infu-Tech, and one that
 we intend to expand through the Smartmeds.com applications."
     Smartmeds.com's recent launch of Smartmedsmobile.com connects individuals
 via their Internet enabled wireless phone to a unique service that will
 empower them to better manage their health via a customized program developed
 to facilitate their daily drug and disease management requirements. Subscriber
 information about this new interactive wireless health service is available at
 http://www.smartmedsmobile.com.
 
     About Infu-Tech/SmartMeds.com
     Infu-Tech is a leading provider of specialty pharmaceuticals and medical
 services. With more than 15 years clinical experience and managed care
 relationships with the enrollees of HMOs, large employer groups, Medicare and
 Medicaid, Infu-Tech has earned a reputation for patient satisfaction and
 clinically proven success in delivering high levels of service to special
 needs patients. Infu-Tech has extended its company's interaction with patients
 via its http://www.smartmeds.com website and Smartmedsmobile.com wireless
 initiative. The Smartmeds.com website includes an online pharmacy, interaction
 with medical professionals, and facilitates the ordering of specialty
 medications and other medical products. Infu-Tech is accredited by the Joint
 Commission on Accreditation of Health Care Organizations (JCAHO), and the
 company's products and services are marketed nationally, Infu-Tech is a
 publicly traded company, NASDAQ SMALLCAP: INFU.
 
     Certain statements contained in this release are forward-looking. Although
 Infu-Tech, Inc. believes that its expectations are based on reasonable
 assumptions within the bounds of its knowledge of its business and operations,
 there can be no assurance that actual results will not differ materially from
 its expectations. Factors that could cause actual results to differ from
 expectations include the difficulty in controlling healthcare costs.
 Integrating new operations from acquired companies and the possible negative
 effects of prospective healthcare reform. For other important factors that may
 cause actual results to differ materially from expectations and underlying
 assumptions, see reports by Infu-Tech, Inc. filed with the Securities and
 Exchange Commission.
 
                     MAKE YOUR OPINION COUNT -- Click Here
                http://tbutton.prnewswire.com/prn/11690X62112265
 
 SOURCE  Infu-Tech, Inc.